Conmed (CNMD) Cash Flow Statement

Click line-items for a historical chart and %

Net income
Depreciation	15.24M
Amortization of debt discount
Amortization, all other	25.97M
Stock-based compensation expense	6.51M
Deferred income taxes	-3.98M
Loss on early extinguishment of debt	254K
Sale of accounts receivable to (collections on behalf of) purchaser
Accounts receivable	11.34M
Inventories	-22.14M
Accounts payable	-3.42M
Income taxes payable
Accrued compensation and benefits	-3.7M
Other assets	-3.04M
Other liabilities	-4.45M
Total	16.68M
Net cash provided by operating activities	24.64M
Purchases of property, plant and equipment	-10.44M
Payments related to business acquisitions	-256.45M
Net cash used in investing activities	-261.71M
Net proceeds from common stock issued under employee plans
Repurchase of treasury stock
Payments on senior credit agreement
Payments on mortgage notes
Proceeds from secured borrowings, net
Payments on senior subordinated notes
Net change in cash overdrafts
Net cash provided by (used in) financing activities	191.42M
Effect of exchange rate changes on cash and cash equivalents	95K
Net increase (decrease) in cash and cash equivalents	-45.56M
Cash and cash equivalents at beginning of period	72.5M
Cash and cash equivalents at end of period	26.95M

Entities mentioned with CNMD

View All Entities